All In Biotech

Drug Trial Radar · NCT00003313

Amifostine in Treating Patients With Stage II or Stage III Non-small Cell Lung Cancer

A Phase III Randomized Study of Amifostine Mucosal Protection for Patients With Favorable Performance Inoperable Stage II-III A/B Non-Small Cell Lung Cancer (NSCLC) Receiving Sequential Induction and Concurrent Hyperfractionated Radiotherapy With Paclitaxel and Carboplatin

Last checked: Nov 20, 2026Latest source record: Nov 21, 2014 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingPhase 3. Randomized with 243 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

243

Actual

Start

Sep 1998

Primary completion

Jul 2002

Study completion Jun 2010

Sponsor

Lead sponsor
Radiation Therapy Oncology GroupResearch network
Sponsor type
Research network
Collaborators
National Cancer Institute (NCI); NRG Oncology
First posted
Nov 26, 2003

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Supportive care
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

RATIONALE: Amifostine may be an effective treatment for the toxic side effects caused by radiation therapy and chemotherapy. It is not yet known whether chemotherapy and radiation therapy are more effective with or without amifostine for non-small cell lung cancer. PURPOSE: Randomized phase III trial to determine the effectiveness of amifostine in treating patients who have stage II or stage III non-small cell lung cancer that cannot be surgically removed and who are undergoing chemotherapy and radiation therapy.

Conditions

  • Drug/Agent Toxicity by Tissue/Organ
  • Lung Cancer
  • Oral Complications
  • Radiation Toxicity

Interventions

  • filgrastimBiological

  • amifostine trihydrateDrug

  • carboplatinDrug

  • paclitaxelDrug

  • radiation therapyRadiation

Primary outcomes

What the sponsor says the trial is designed to measure.

No primary outcomes listed.

Locations

264 sites in 2 countries. Site status is shown where the registry gives one.

  • University of Alabama at Birmingham Comprehensive Cancer Center

    Birmingham, Alabama

  • Huntsville Hospital System

    Huntsville, Alabama

  • Comprehensive Cancer Institute of Huntsville

    Huntsville, Alabama

  • MBCCOP - Gulf Coast

    Mobile, Alabama

  • Alabama Oncology, LLC

    Montgomery, Alabama

  • Radiation Oncology Associates of West Alabama

    Tuscallosa, Alabama

  • Providence Alaska Medical Center

    Anchorage, Alaska

  • Foundation for Cancer Research and Education

    Phoenix, Arizona

  • Arizona Cancer Center

    Tucson, Arizona

  • University of Arkansas for Medical Sciences

    Little Rock, Arkansas

  • Mount Diablo Medical Center

    Concord, California

  • Cancer Center and Beckman Research Institute, City of Hope

    Duarte, California

  • California Cancer Center

    Fresno, California

  • Saint Agnes Cancer Center

    Fresno, California

  • Glendale Memorial Hospital and Health Center

    Glendale, California

  • Sutter Health West Cancer Research Group

    Greenbrae, California

  • University of California San Diego Cancer Center

    La Jolla, California

  • Loma Linda University Medical Center

    Loma Linda, California

  • Veterans Affairs Medical Center - Long Beach

    Long Beach, California

  • USC/Norris Comprehensive Cancer Center and Hospital

    Los Angeles, California

  • Jonsson Comprehensive Cancer Center, UCLA

    Los Angeles, California

  • CCOP - Bay Area Tumor Institute

    Oakland, California

  • Huntington Cancer Center

    Pasadena, California

  • Cancer Care Center

    Pomona, California

  • Radiation Oncology Center - Sacramento

    Sacramento, California

  • Radiation Medical Group, Inc.

    San Diego, California

  • UCSF Cancer Center and Cancer Research Institute

    San Francisco, California

  • O'Connor Hospital

    San Jose, California

  • CCOP - Santa Rosa Memorial Hospital

    Santa Rosa, California

  • David Grant Medical Center

    Travis Air Force Base, California

  • Memorial Hospital Cancer Center

    Colorado Springs, Colorado

  • University of Colorado Cancer Center

    Denver, Colorado

  • Saint Mary's Hospital and Medical Center

    Grand Junction, Colorado

  • CCOP - Christiana Care Health Services

    Wilmington, Delaware

  • Walter Reed Army Medical Center

    Washington D.C., District of Columbia

  • Lykes Center for Radiation Therapy

    Clearwater, Florida

  • Halifax Medical Center

    Daytona Beach, Florida

  • Radiation Therapy Associates - Fort Myers

    Fort Myers, Florida

  • University of Florida Health Science Center

    Gainesville, Florida

  • Health First Holmes Regional Medical Center

    Melbourne, Florida

Showing 40 of 264 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.